Sanskruti Pharma — Rituximab Exporter Profile
Indian Pharmaceutical Exporter · #12 for Rituximab · $71.6K export value · DGFT Verified
Sanskruti Pharma is the #12 Indian exporter of Rituximab with $71.6K in export value and 62 verified shipments. Sanskruti Pharma holds a 0.4% market share in Rituximab exports across 3 countries. The company exports 2 pharmaceutical products worth $84.9K across 1 therapeutic categories.
Sanskruti Pharma — Rituximab Export Profile: Buyers & Destinations
Where Does Sanskruti Pharma Export Rituximab?
| Country | Value | Shipments | Share |
|---|---|---|---|
| BURKINA FASO | $67.9K | 60 | 94.9% |
| PHILIPPINES | $2.9K | 1 | 4.0% |
| GHANA | $761 | 1 | 1.1% |
Sanskruti Pharma exports Rituximab to 3 countries. The largest destination is BURKINA FASO accounting for 94.9% of Sanskruti Pharma's Rituximab shipments, followed by PHILIPPINES (4.0%) and GHANA (1.1%). These destinations reflect Sanskruti Pharma's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Rituximab from Sanskruti Pharma?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| TO THE ORDER | BURKINA FASO | $36.8K | 29 |
| TO THE ORDER, | BURKINA FASO | $28.8K | 30 |
| CLIENT CODE PH001 | PHILIPPINES | $2.9K | 1 |
| GHANA CLIENT GH970 MANAGERK PREKOHALE PHARMACY LIMITED | GHANA | $761 | 1 |
Sanskruti Pharma supplies Rituximab to 4 buyers globally. The largest buyer is TO THE ORDER (BURKINA FASO), followed by TO THE ORDER, (BURKINA FASO) and CLIENT CODE PH001 (PHILIPPINES). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Rituximab Export Value and How Much Does Sanskruti Pharma Contribute?
India exported $9.4M worth of Rituximab through 1,215 shipments from 164 suppliers to 104 countries, serving 292 buyers globally. Sanskruti Pharma contributes $71.6K to this total, accounting for 0.4% of India's Rituximab exports. Sanskruti Pharma ships Rituximab to 3 countries through 4 buyers.
What Is the Average Shipment Value for Sanskruti Pharma's Rituximab Exports?
Sanskruti Pharma's average Rituximab shipment value is $1.2K per consignment, based on 62 shipments totaling $71.6K. The largest destination is BURKINA FASO (94.9% of Sanskruti Pharma's Rituximab exports).
How Does Sanskruti Pharma Compare to Other Indian Rituximab Exporters?
Sanskruti Pharma ranks #12 among 164 Indian Rituximab exporters with a 0.4% market share. The top 3 exporters are RELIANCE LIFE SCIENCES PRIVATE LIMITED ($4.1M), DR.REDDY'S LABORATORIES LTD ($3.2M), DR REDDYS LABORATORIES LIMITED ($550.0K). Sanskruti Pharma processed 62 shipments to 3 destination countries.
What Rituximab Formulations Does Sanskruti Pharma Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| RITUXIREL 500(RITUXIMAB 500MG INJECTION),PACK:VIAL | $8.6K | 2 |
| RITUXIREL 500MG(RITUXIMAB 500MG INJ),PAC | $5.3K | 2 |
| RITUXIREL-500 (RITUXIMAB INJ 500MG),PACK | $4.2K | 3 |
| RITUXIREL 500MG (RITUXIMAB 500MG INJECTION),PACK:VIAL | $3.6K | 3 |
| RITUXIREL 500MG(RITUXIMAB 500MG INJ) | $3.3K | 3 |
| RITUXIREL 500 RITUXIMAB 500MG INJECTION PACK VIAL | $3.1K | 1 |
| MABTAS 500 (RITUXIMAB 500MG INJECTION) , PACK - VIAL | $2.9K | 1 |
| RITUXIREL 500(RITUXIMAB 500MG INJECTION) (PACK B/10=1 BOX),PACK:VIAL | $2.7K | 1 |
| RITUXIREL 500(RITUXIMAB 500MG INJ) | $2.6K | 3 |
| RITUXIREL 500 (RITUXIMAB INJECTION 500MG | $2.3K | 1 |
Sanskruti Pharma exports 45 distinct Rituximab formulations including tablets, capsules, syrups, and combination drugs. The top formulation is RITUXIREL 500(RITUXIMAB 500MG INJECTION),PACK:VIAL with 2 shipments worth $8.6K.
How Does Sanskruti Pharma Compare to Nearest Rituximab Exporters?
Exporters ranked immediately above and below #12 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 10 | RMPL PHARMA LLP | $92.7K | 55 | 9 | $1.7K |
| 11 | PNT PHARMA | $86.7K | 12 | 1 | $7.2K |
| 12 | SANSKRUTI PHARMA ★ | $71.6K | 62 | 3 | $1.2K |
| 13 | HEET HEALTHCARE PRIVATE LIMITED | $58.3K | 10 | 3 | $5.8K |
| 14 | DOSHI MEDICARE PRIVATE LIMITED | $55.6K | 14 | 5 | $4.0K |
Sanskruti Pharma ranks #12 among 164 Indian Rituximab exporters. Average shipment value of $1.2K compared to the market average of $57.4K. The closest competitors by value are RMPL PHARMA LLP and PNT PHARMA.
Which Indian Ports Ship Rituximab Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 389 | 32.0% |
| SAHAR AIR CARGO ACC (INBOM4) | 325 | 26.7% |
| Bombay Air | 85 | 7.0% |
| Bombay Air Cargo | 58 | 4.8% |
| HYDERABAD ACC (INHYD4) | 46 | 3.8% |
| DELHI AIR CARGO ACC (INDEL4) | 45 | 3.7% |
| DELHI AIR | 35 | 2.9% |
| AHEMDABAD AIR | 26 | 2.1% |
What Other Advanced Oncology Products Does Sanskruti Pharma Export?
Sanskruti Pharma also exports these advanced oncology products. Each links to the detailed product page.
About Sanskruti Pharma
Sanskruti Pharma exports 2 products worth $84.9K. Beyond Rituximab, top products include Regorafenib. View the complete Sanskruti Pharma profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Rituximab — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Rituximab shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Sanskruti Pharma matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 62 individual customs records matching Sanskruti Pharma exporting Rituximab, covering 45 formulations to 3 countries via 4 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 104+ countries, 292+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Rituximab Export Data from Sanskruti Pharma
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Sanskruti Pharma's Rituximab exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Sanskruti Pharma
Full Company Profile →
2 products · $84.9K total trade · 1 categories
Rituximab Stats
Company Overview
Top Products by Sanskruti Pharma
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Sanskruti Pharma.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Rituximab. For current shipment-level data, contact TransData Nexus.